Skip To Main Content

This platform is for Australian healthcare professionals only

Campus

Products

Login
Registration

Science
Oncology

Anticoagulation
Video Library
Content Library

Dermatology
Atopic Dermatitis

Diabetes
Content Library
Video Library
Diabetes Clinical Paper Summaries
Diabetes Congress Reports

Rare blood disorders
ALPROLIX
ELOCTATE
Support
Resource Centre

Rare Disease
Diagnostic Testing

Fabry Disease
Content Library

Pompe Disease
Video Library
Content Library

Respiratory
Content Library
CRSwNP

Asthma
Comorbid Severe Asthma and CRS/NP
Results from VESTIGE

Medical education
BR1DGE T1D programme

Advent programme
ADVENT Respiratory
ADVENT Aspire
ADVENT Knowledge Centre
ADVENT Dermatology

Neurology
NEUROLOGY OPEN ACCESS
LEMTRADA OPEN ACCESS

Patient Support
Anticoagulation
Diabetes

Dermatology

Atopic Dermatitis
Patient Support material

Respiratory
CRSwNP

Asthma
Video Library

Campus

Products

Science
Oncology

Anticoagulation
Video Library
Content Library

Dermatology
Atopic Dermatitis

Diabetes
Content Library
Video Library
Diabetes Clinical Paper Summaries
Diabetes Congress Reports

Rare Blood Disorders
ALPROLIX
ELOCTATE
Support
Resource Centre

Rare Disease
Diagnostic Testing

Fabry Disease
Content Library

Pompe Disease
Video Library
Content Library

Respiratory
Content Library
CRSwNP

Asthma
Comorbid Severe Asthma and CRS/NP
Results from VESTIGE

Medical education
BR1DGE T1D programme

Advent programme
ADVENT Respiratory
ADVENT Aspire
ADVENT Knowledge Centre
ADVENT Dermatology

Neurology
NEUROLOGY OPEN ACCESS
LEMTRADA OPEN ACCESS

Patient Support
Anticoagulation
Diabetes

Dermatology

Atopic Dermatitis
Patient Support material

Respiratory
CRSwNP

Asthma
Video Library

Login
Registration

Diabetes Clinical Paper Summaries

MAT-AU-2301722 - 1.0 - 04/2024

Campus

Follow Us:

Back to top

About Contact us Cookie policy Legal notice Privacy notice Site map

© Sanofi – All rights reserved

MAT-AU-2301722 - 1.0 - 04/2024

sanofi-aventis australia pty ltd trading as Sanofi ABN 31 008 558 807. Talavera Corporate Centre, Building D, 12-24, Talavera Road, Macquarie Park, NSW 2113.

leave-site-modal-text

You will now be leaving the site

You are now leaving campus.sanofi/au

Campus Sanofi Australia does not review the information contained on this website and/or database for content, accuracy or completeness. Use of and access to this information is subject to the terms, limitations and conditions set by the website and/or database producer.

Campus Sanofi Australia makes no representation as to the accuracy or any other aspect of the information contained on such website and/or database, nor does Campus Sanofi Australia necessarily endorse such website and/or database.
The information the reader is about to be referred to may not comply with the Australian regulatory requirements. Further information relevant to the Australian environment is available from the company or via the Product Information.

Continue

Waddling-Gait---Robert,-28-year-old-mild-LOPD-patient

Reaching-Overhead---Robert,-28-year-old-mild-LOPD-patient

Standing-From-Sitting---Robert,-28-year-old-mild-LOPD-patient

Climbing-Stairs---Robert,-28-year-old-mild-LOPD-patient

Waddling-Gait---Karen,-18-year-old-moderate-LOPD-patient

Reaching-Overhead---Karen,-18-year-old-moderate-LOPD-patient

Standing-From-Sitting---Karen,-18-year-old-moderate-LOPD-patient

Climbing-Stairs---Karen,-18-year-old-moderate-LOPD-patient

ASPIRE-ICT-1-23_Harrington_MAT-AU-2302788-1

ASPIRE-ICT-1-23_Kyle-Blakey_MAT-AU-2302789-1

Which-biologic-and-why--When-to-switch-to-another-one-

Waddling-Gait---Brian,-44-year-old-severe-LOPD-patient

Reaching-Overhead---Brian,-44-year-old-severe-LOPD-patient

Standing-From-Sitting---Brian,-44-year-old-severe-LOPD-patient

Climbing-Stairs---Brian,-44-year-old-severe-LOPD-patient

RESP-ICT2_Wark_MAT-AU-2301970

RESP-ICT2_Stone_MAT-AU-2301972

Remission-in-rheumatology---Dr-Michelle-Tellus

Pavord_MAT-AU-2300571

Wark_MAT-AU-2300572

Q-A-Discussion_MAT-AU-2300573

RESP-ICT3_Tellus_MAT-AU-2302033

RESP-ICT3_Lee_MAT-AU-2302034

RESP-ICT3_Hew_MAT-AU-2302035

Reduced-need-for-sinus-surgery

Up-to-45--of-severe-asthma-patients-have-comorbid-CRSwNP

Severe-asthma-with-comorbid-CRSwNP-leads-to-more-severe-disease

Less-rescue-oral-corticosteriod-use

Improved-sense-of-smell

Reduced-obstruction-and-congestion

Reduced-asthma-exacerbations-and-improved-lung-function

IL-4-and-IL-13-are-key-and-central-drivers-of-type-2-inflammation

Gaucher-diagnosis-1

RESP-ICT2_Debate_MAT-AU-2301973

RESP-ICT3_Q-A_MAT-AU-2302036

ASPIRE-ICT-1-23_Harrington_MAT-AU-2302788-1

ASPIRE-ICT-1-23_Kyle-Blakey_MAT-AU-2302789-1

Which-biologic-and-why--When-to-switch-to-another-one-

ASPIRE-ICT1-23_Q-A_MAT-AU-2302791-1

RESP-ICT2_Stone_CS_MAT-AU-2301975

RESP-ICT2_Wark_CS_MAT-AU-2301974

RESP-ICT2_Panel-Discussion_MAT-AU-2301976

SANA7993_Safety-Page-Tables_V0.2_1_New3

Products_Dermatology_Atopic-Dermatitis_Adverse-Events-Adults_18012021

RESP-ICT3_Q-A_MAT-AU-2302036